We conducted a prospective nested case-control study among military service members to investigate whether antibodies against tetanus or diphtheria predict multiple sclerosis (MS) risk. Paired T-tests were used to compare means of anti-tetanus and diphtheria toxoids among 56 MS cases and 112 matched controls. Conditional logistic regression was used to estimate odds ratios (OR). There were no differences between the mean serum IgG antibodies against tetanus (p-value 0.28) or diphtheria (p-value 0.45) in the baseline samples. The OR of MS associated with 1 standard deviation difference in antibody titers was 0.76 (95% CI: 0.48-1.21) for tetanus (SD = 4.71) and 1.03 (0.73-1.45) for diphtheria (SD = 0.87). Results of this study suggest serum IgG antibodies against tetanus or diphtheria are not predictors of MS risk.
Introduction
Previous studies have suggested that tetanus vaccination is associated with a decreased risk of multiple sclerosis (MS) (Hernan et al., 2006) and that individuals with MS have lower IgG antibodies against tetanus and diphtheria toxoid (Lamoureux et al., 1976) . It has been hypothesized that because the tetanus toxoid contains a universal human T-helper cell epitope, it may shift type 1 (pro-inflammatory cytokines) to type 2 (anti-inflammatory cytokines) responses to environmental stimuli and reduce MS risk (Etlinger et al., 1990; Hernan et al., 2006; Vandenbark et al., 1996) . The mechanism by which immunization to diphtheria could alter risk of MS is unclear, however it might be related to intrathecal immunoglobulin production (Salmi et al., 1981) . To further investigate these hypotheses, we conducted a prospective study to determine whether antibodies against tetanus or diphtheria in healthy individuals predict their future risk of MS. A strength of this study is that antibody titers were measured in blood samples collected several years before the onset of the first neurological symptoms of MS (MS onset).
Methods
We conducted a prospective, nested case-control study among 7 million military service members with serum stored in the Department of Defense Serum Repository (DoDSR). Since 1985, military personnel are routinely tested for HIV at entry into the military and on average, every 2 years thereafter. The residual serum samples from this testing are catalogued and stored by the DoDSR. As previously described (Munger et al., 2006) , we have confirmed 315 cases of MS among active duty personnel in the US Army (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) and Navy (1992 Navy ( -2004 with at least one, but up to three, samples collected before their date of MS onset in the DoDSR. The current study includes 56 of these cases occurring in the US Army between January 1998 and July 2000. The average number of years between baseline sample collection and MS onset was 5.54. Each MS case was matched with two controls on age (+/−1 year), sex, race (white, black, Hispanic, other), and date of serum collection (+/−30 days). IgG antibodies to tetanus and diphtheria toxoids were measured by indirect ELISA from The Binding Site, San Diego, CA. The assays use the quantitative sandwich enzyme immunoassay technique. The reproducibility of the assays was assessed using blind quality control serum samples, each split into three identical aliquots. These samples were run at the same time as the MS case and control samples. The coefficients of variation for the intra-assay samples for anti-tetanus toxoid was 14.2% and E-mail address: jmassa@hsph.harvard.edu (J. Massa).
